Seamless Connectivity Between Platforms Empowers Providers to Optimize Operations and Enhance Pediatric Patient Care NEW YORK, April 3, 2025 /PRNewswire/...
Sensi brings renowned dementia and aging care expert Teepa Snow's proven strategies to the point of care—blending AI with human...
De-Risking Target Validation with Data-Driven Genomic Insights ROME, April 3, 2025 /PRNewswire/ -- IRBM, an integrated Contract Research Organization (CRO)...
WASHINGTON, April 3, 2025 /PRNewswire/ -- The Lilabean Foundation (LBF) is playing a critical role in advancing pediatric brain cancer research...
YOKNEAM ILLIT, Israel, April 3, 2025 /PRNewswire/ -- Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory...
KENNEWICK, Wash., April 3, 2025 /PRNewswire/ -- Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring and sleep solutions, launched its...
Membership will bolster the ranks of academic and community hospitals joining the Ryght Research Network to streamline clinical trials with...
New Survey Reveals 30% of Middle-Aged Women are Embracing Sober Curiosity as 45% Express Dependency Concerns DENVER, April 3, 2025...
BOSTON, April 3, 2025 /PRNewswire/ -- Lindus Health, the anti-CRO running radically faster, more reliable trials, has been awarded funding...
Center for Social Dynamics has selected Floreo to expand delivery of immersive, virtual services incorporating VR autism therapy to schools nationwide....
An INRS study based on natural selection is paving the way for very promising advances in biosurfactants. LAVAL, QC, April 3,...
Presession focused on MDS/MPN-related anemia. Participants can register for the presession and SOHO 2025 at soho.click/2025 . HOUSTON, April 3, 2025...
Denver, Colorado--(Newsfile Corp. - April 3, 2025) - CBD of Denver, Inc. (OTC Pink: CBDD), a diversified holding company focused...
Esteemed Life Sciences Leader Joins Board to Enhance Strategic Direction During Company Expansion Ben Daverman, Vantive Chief Strategy Officer Joins...
New data to be presented from Company’s lead product candidate SENTI-202 for the treatment of relapsed/refractory acute myeloid leukemia (r/r...
Academic research teams of selected projects participate in a translational research program that eliminates barriers that prevent promising discoveries from...
FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosisSAN DIEGO, April 03,...
$3.1 million of new orders received during the current calendar year$6.6 million customer program backlog expected to be delivered over...
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on...
Comes on the heels of company’s rebranding and new strategic direction, advancing its lead program in ovarian cancerCAMBRIDGE, Mass., April...